Northwestern scientists recently identified a new protein complex that is upregulated in acute myeloid leukemia, potentially explaining why current therapies are often ineffective.
Reduced blood capillaries in the back of the eye may be a new, noninvasive way to diagnose early cognitive impairment, a precursor to Alzheimer’s disease.
Higher levels of urinary oxalate excretion were associated with a higher risk of chronic kidney disease progression, according to a study published in JAMA Internal Medicine.
More than 450 scientists, trainees, students and faculty presented posters and abstracts at Feinberg’s 15th Annual Lewis Landsberg Research day — the largest celebration of scientific investigation at Feinberg to date.
An experimental treatment originally intended to help patients recover from stroke may have beneficial effects for Alzheimer’s disease, according to a recent study.
Andrew Furman, a third-year student in the MD-MBA dual-degree program, has worked with Erie Family Health Centers as part of his participation in Second Opinions, a pro-bono healthcare consulting student organization.
Interruptions in circadian rhythm protected against damage in a model of Huntington’s disease, suggesting an unexpected neuroprotective effect for mild stress to the brain from irregular patterns of sleep.
Feinberg investigators are conducting basic science research, epidemiological studies and drug trials of new therapies for food allergies to uncover the breadth of the problem, understand the basic cellular pathways and develop new avenues of treatment.
Kathleen Green, PhD, the Joseph L. Mayberry, Sr., Professor of Pathology and Toxicology and professor of Dermatology, has been named the winner for the 2019 Tripartite Legacy Faculty Prize in Translational Science and Education.
Measures of structural changes derived from cardiac magnetic resonance imaging (CMR) have significant potential as a noninvasive way to measure the risk of heart transplant rejection, according to a new study.